Overview
Status
Active
Registry date
2016-01-18
Share capital
150,000.00 PLN
Registered address
ul. Henryka Wieniawskiego 40, 93-564 Łódź, Poland
Website
Email
Electronic delivery address
AE:PL-63130-42587-TRARH-14
Financials
Revenue history (in k)
Filing timeliness
Financial statements were filed on time, on average 38 days early.
- 202504/07/2026
- 202428/06/2025
- 202319/06/2024
- 202223/05/2023
- 202128/06/2022
- 202005/07/2021
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Industry
Authorized Representatives
Damian Przemysław Kolasa – Management Board Member
Tomasz Mateusz Gitner – President of the Management Board
Krystian Kolasa – Management Board Member
Manner of representation
Each member of the management board is authorised to make declarations of will on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Tomasz Mateusz Gitnerage 50 | 480 | $12,965.96 | 32% |
Damian Przemysław Kolasaage 48 | 540 | $14,586.71 | 36% |
Krystian Kolasaage 44 | 300 | $8,103.73 | 20% |
Others | 180 | $4,862.24 | 12% |
Damian Przemysław Kolasa and Krystian Kolasa hold a combined 56% – the ownership structure indicates family control.
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2016-01-30.
90 1050 1461 1000 0090 3084 7298
Debt
No entries in the National Debtors Register (KRZ).
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jul 1, 2020 | Aid for SME access to finance — aid for start-ups | $48,632$48,632 | Blue Dot Solutions sp. z o.o. | |
| Jun 1, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $1,282$1,282 | Prezydent Miasta Łódź |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Read-GeneS.A. | $2,163,474.84 | read-gene.com | ||
| Proteon PharmaceuticalsS.A. | $2,026,826.52 | proteonpharmaspolkaakcyjna.pl | ||
| Centrum Badań Weterynaryjnych Vetcomplexsp. z o.o. | $255,522.81 | vetcomplex.pl | ||
| UveraS.A. | $155,384.29 | uvera.eu | ||
| Luna Laboratorysp. z o.o. | $61,894.23 | lunalab.pl | ||
| Biostat Research And Developmentsp. z o.o. | $50,225.77 | biostat.com.pl | ||
| Detoxedsp. z o.o. | $11,972.37 | detoxed.pl | ||
| Dairy Biotechnologiessp. z o.o. | $1,485.09 | milcu.eu | ||
| Aiventrosp. z o.o. | $0.00 | aiventro.com | ||
| BioencaS.A. | $0.00 | bioenca.pl |
FAQ
The main business activity of Mediam Chemical focuses on research and experimental development on biotechnology.
The company was registered in the Polish National Court Register (KRS) on January 18, 2016.
The headquarters is located at: ul. Henryka Wieniawskiego 40, 93-564 Łódź.
The management board consists of: Damian Przemysław Kolasa (Member of the Management Board), Tomasz Mateusz Gitner (President of the Management Board), and Krystian Kolasa (Member of the Management Board).
The share capital of the company is PLN 150,000 (approx. $40,519).
The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.
Last updated: 2026-10-07